Legislation and Legislative Advocacy
The American Hospital Association (AHA) shares resources on health care legislation being considered by the U.S. House and Senate and legislative advocacy opportunities for hospitals and health systems.
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.
The AHA urges Senate appropriators to support federal funding for research and education to reduce violence in communities
Two House committees today marked up revised versions of the Lower Prescription Drug Costs Now Act (H.R. 3) — legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
Congress should pass legislation that protects patients from surprise medical bills and rejects rate setting, hospital leaders said today at an AHA briefing on Capitol Hill.
The Food and Drug Administration last week updated 2017 draft guidance to clarify the categories of clinical and decision support software subject to FDA oversight under the 21st Century Cures Act based on risk.
The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act, H.R. 4538, bipartisan legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals.
The House Energy and Commerce Subcommittee on Health today held a hearing to discuss four bills aimed at making prescription drugs more affordable for Americans.
Nearly 100 hospital and health system leaders today came together in Washington, D.C., to urge lawmakers to take action on critical issues facing patients and protect access to care.
The Centers for Medicare & Medicaid Services today issued a final rule delineating a methodology for implementing the Affordable Care Act aggregate reductions to state Medicaid Disproportionate Share Hospital allotments beginning in fiscal year 2020.
House Democratic leaders today released the Lower Drug Costs Now Act, a bill that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.